Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Buy
68,500
+43,800
+177% +$1.11M ﹤0.01% 6151
2025
Q4
$484K Sell
24,700
-2,200
-8% -$46.5K ﹤0.01% 9097
2025
Q3
$555K Sell
26,900
-92,600
-77% -$1.86M ﹤0.01% 8871
2025
Q2
$1.99M Buy
119,500
+6,700
+6% +$112K ﹤0.01% 5707
2025
Q1
$1.86M Buy
112,800
+19,900
+21% +$385K ﹤0.01% 5668
2024
Q4
$1.81M Buy
92,900
+61,400
+195% +$1.5M ﹤0.01% 5842
2024
Q3
$1.08M Sell
31,500
-2,500
-7% -$91.7K ﹤0.01% 6732
2024
Q2
$1.32M Buy
34,000
+29,100
+594% +$1.04M ﹤0.01% 6082
2024
Q1
$171K Sell
4,900
-29,900
-86% -$1.02M ﹤0.01% 10565
2023
Q4
$1.06M Buy
34,800
+32,100
+1,189% +$947K ﹤0.01% 6556
2023
Q3
$74.3K Sell
2,700
-3,800
-58% -$96.5K ﹤0.01% 11258
2023
Q2
$157K Sell
6,500
-14,400
-69% -$401K ﹤0.01% 10270
2023
Q1
$651K Sell
20,900
-35,600
-63% -$1.08M ﹤0.01% 7750
2022
Q4
$1.65M Buy
+56,500
New +$1.52M ﹤0.01% 5851

Other funds holding TRMD

Citadel Advisors's TRMD Position: Q1 2026 in Review

Citadel Advisors increased its TORM (TRMD) stake by 399% in Q1 2026, buying an estimated $4.49M and bringing the position to 220,450 shares worth $6.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4009.

Citadel Advisors first reported a position in TRMD in Q2 2022 and has held it in 15 quarters since. The position peaked at $19M in Q3 2024. 141 funds tracked by Wall St. Rank hold TRMD as of Q1 2026.

  • Citadel Advisors held 220,450 shares of TORM worth $6.15M as of Q1 2026.
  • Citadel Advisors bought 176,285 TORM shares in Q1 2026, an estimated $4.49M.
  • TORM made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4009 holding.
  • Citadel Advisors first reported a position in TORM in Q2 2022 and has held it in 15 quarters since.
  • Citadel Advisors's TORM position peaked at $19M in Q3 2024.
  • 141 funds tracked by Wall St. Rank held TORM as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.